Morgan Stanley’s Kewaunee Scientific KEQU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$683K Buy
19,934
+2,800
+16% +$108K ﹤0.01% 5324
2025
Q4
$641K Sell
17,134
-1,018
-6% -$41.4K ﹤0.01% 5393
2025
Q3
$774K Sell
18,152
-872
-5% -$46.9K ﹤0.01% 5287
2025
Q2
$1.12M Sell
19,024
-3,693
-16% -$137K ﹤0.01% 5038
2025
Q1
$895K Buy
22,717
+3,837
+20% +$215K ﹤0.01% 5053
2024
Q4
$1.17M Sell
18,880
-1,622
-8% -$66K ﹤0.01% 5017
2024
Q3
$683K Buy
20,502
+12
+0.1% +$563 ﹤0.01% 5247
2024
Q2
$967K Sell
20,490
-3,600
-15% -$136K ﹤0.01% 4979
2024
Q1
$829K Sell
24,090
-24,790
-51% -$734K ﹤0.01% 5070
2023
Q4
$1.42M Buy
48,880
+23,340
+91% +$473K ﹤0.01% 5127
2023
Q3
$441K Hold
25,540
﹤0.01% 5226
2023
Q2
$387K Hold
25,540
﹤0.01% 5343
2023
Q1
$393K Sell
25,540
-1,751
-6% -$27.8K ﹤0.01% 5395
2022
Q4
$423K Buy
27,291
+111
+0.4% +$1.87K ﹤0.01% 5325
2022
Q3
$478K Hold
27,180
﹤0.01% 5292
2022
Q2
$452K Sell
27,180
-2
-0% -$29 ﹤0.01% 5471
2022
Q1
$394K Sell
27,182
-998
-4% -$14K ﹤0.01% 5545
2021
Q4
$358K Sell
28,180
-700
-2% -$8.94K ﹤0.01% 5749
2021
Q3
$386K Hold
28,880
﹤0.01% 5649
2021
Q2
$416K Buy
28,880
+11,700
+68% +$144K ﹤0.01% 5638
2021
Q1
$212K Sell
17,180
-4,200
-20% -$52.4K ﹤0.01% 5633
2020
Q4
$267K Buy
21,380
+2,100
+11% +$19.4K ﹤0.01% 5440
2020
Q3
$172K Buy
19,280
+1,925
+11% +$18.3K ﹤0.01% 5184
2020
Q2
$161K Hold
17,355
﹤0.01% 5180
2020
Q1
$138K Sell
17,355
-625
-3% -$6.92K ﹤0.01% 5043
2019
Q4
$242K Sell
17,980
-600
-3% -$9.39K ﹤0.01% 5337
2019
Q3
$290K Sell
18,580
-225
-1% -$3.79K ﹤0.01% 4946
2019
Q2
$360K Sell
18,805
-263
-1% -$5.64K ﹤0.01% 4766
2019
Q1
$401K Sell
19,068
-5,857
-23% -$166K ﹤0.01% 4692
2018
Q4
$828K Sell
24,925
-156
-0.6% -$4.26K ﹤0.01% 4420
2018
Q3
$790K Sell
25,081
-696
-3% -$23.1K ﹤0.01% 4705
2018
Q2
$927K Buy
25,777
+221
+0.9% +$7.46K ﹤0.01% 4676
2018
Q1
$871K Buy
25,556
+1,700
+7% +$49.8K ﹤0.01% 4639
2017
Q4
$691K Buy
23,856
+8,606
+56% +$248K ﹤0.01% 4789
2017
Q3
$450K Sell
15,250
-700
-4% -$18.4K ﹤0.01% 4949
2017
Q2
$397K Buy
15,950
+1,550
+11% +$35.9K ﹤0.01% 4949
2017
Q1
$331K Sell
14,400
-4,866
-25% -$118K ﹤0.01% 5071
2016
Q4
$471K Buy
19,266
+100
+0.5% +$2.36K ﹤0.01% 4971
2016
Q3
$456K Buy
19,166
+600
+3% +$13.2K ﹤0.01% 4581
2016
Q2
$351K Sell
18,566
-488
-3% -$8.24K ﹤0.01% 4620
2016
Q1
$317K Sell
19,054
-348
-2% -$5.83K ﹤0.01% 4699
2015
Q4
$345K Buy
19,402
+2,705
+16% +$45.8K ﹤0.01% 4782
2015
Q3
$273K Sell
16,697
-1,505
-8% -$25.3K ﹤0.01% 4933
2015
Q2
$308K Sell
18,202
-1,963
-10% -$33K ﹤0.01% 5012
2015
Q1
$353K Sell
20,165
-576
-3% -$10.2K ﹤0.01% 4877
2014
Q4
$369K Sell
20,741
-1,485
-7% -$26.2K ﹤0.01% 4888
2014
Q3
$397K Sell
22,226
-275
-1% -$4.94K ﹤0.01% 4725
2014
Q2
$389K Sell
22,501
-500
-2% -$8.27K ﹤0.01% 4757
2014
Q1
$375K Sell
23,001
-1,496
-6% -$24.4K ﹤0.01% 4752
2013
Q4
$382K Sell
24,497
-6,764
-22% -$114K ﹤0.01% 4642
2013
Q3
$537K Buy
31,261
+7,406
+31% +$108K ﹤0.01% 4281
2013
Q2
$302K Buy
+23,855
New +$312K ﹤0.01% 4600

Other funds holding KEQU

Morgan Stanley's KEQU Position: Q1 2026 in Review

Morgan Stanley increased its Kewaunee Scientific (KEQU) stake by 16% in Q1 2026, buying an estimated $108K and bringing the position to 19,934 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #5324.

Morgan Stanley first reported a position in KEQU in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.42M in Q4 2023. 32 funds tracked by Wall St. Rank hold KEQU as of Q1 2026.

  • Morgan Stanley held 19,934 shares of Kewaunee Scientific worth $683K as of Q1 2026.
  • Morgan Stanley bought 2,800 Kewaunee Scientific shares in Q1 2026, an estimated $108K.
  • Kewaunee Scientific made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5324 holding.
  • Morgan Stanley first reported a position in Kewaunee Scientific in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's Kewaunee Scientific position peaked at $1.42M in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.